BioCryst Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US09058V1035

SecurityBCRX / BioCryst Pharmaceuticals, Inc.
InstitutionAlps Advisors Inc
Latest Disclosed Ownership60,250 shares
Latest Disclosed Value $ 573,580
Alps Advisors Inc ownership in BCRX / BioCryst Pharmaceuticals, Inc.

On May 8, 2026 - Alps Advisors Inc filed a 13F-HR form disclosing ownership of 60,250 shares of BioCryst Pharmaceuticals, Inc. (US:BCRX) valued at $573,580 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 0 shares of BioCryst Pharmaceuticals, Inc.. The current value of the position is $497,062 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 60,250 60,250 574 0.0025
2026-02-12 2025-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -101,125 -100.00 0 -100.00
2025-11-05 2025-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 101,125 -11,710 -10.38 768 -24.13 0.0043
2025-08-11 2025-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 112,835 -40,150 -26.24 1,011 -11.86 0.0058
2025-04-30 2025-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 152,985 -14,507 -8.66 1,147 -8.90 0.0067
2025-02-13 2024-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 167,492 9,382 5.93 1,260 4.83 0.0079
2024-11-12 2024-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 158,110 -2,893 -1.80 1,202 20.82 0.0080
2024-08-13 2024-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 161,003 15,597 10.73 995 34.69 0.0068
2024-05-14 2024-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 145,406 7,305 5.29 739 -10.76 0.0052
2024-02-14 2023-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 138,101 -1,749 -1.25 827 -16.46 0.0065
2023-11-14 2023-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 139,850 972 0.70 990 1.33 0.0082
2023-08-14 2023-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 138,878 16,060 13.08 978 -4.59 0.0085
2023-05-10 2023-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 122,818 -3,555 -2.81 1,024 -29.38 0.0091
2023-02-14 2022-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 126,373 24,834 24.46 1,451 13.37 0.0129
2022-11-14 2022-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 101,539 -8,576 -7.79 1,279 9.79 0.0121
2022-08-15 2022-06-30 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 110,115 110,115 1,165 0.0113
2022-08-11 2022-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 110,115 110,115 1,165 0.0112
2018-10-25 2018-09-30 13F BioCryst Pharmaceuticals COMMON STOCK 09058V103 0 -109,044 -100.00 0 -100.00
2018-07-31 2018-06-30 13F/A-1 BioCryst Pharmaceuticals COMMON STOCK 09058V103 109,044 -22,977 -17.40 535 -15.08 0.0034
2018-07-25 2018-06-30 13F BioCryst Pharmaceuticals COMMON STOCK 09058V103 109,044 -22,977 535
2018-05-01 2018-03-31 13F BioCryst Pharmaceuticals COMMON STOCK 09058V103 132,021 22,977 21.07 630 17.76 0.0050
2018-02-20 2017-12-31 13F/A-1 BioCryst Pharmaceuticals COMMON STOCK 09058V103 109,044 29,841 37.68 535 28.92 0.0037
2018-02-05 2017-12-31 13F BioCryst Pharmaceuticals COMMON STOCK 09058V103 109,044 29,841 535
2017-11-03 2017-09-30 13F BioCryst Pharmaceuticals COMMON STOCK 09058V103 79,203 6,612 9.11 415 2.72 0.0029
2017-08-03 2017-06-30 13F BioCryst Pharmaceuticals COMMON STOCK 09058V103 72,591 72,591 404 0.0028
2016-07-27 2016-06-30 13F BioCryst Pharma Common Stock 09058V103 0 -82,476 -100.00 0 -100.00
2016-05-10 2016-03-31 13F BioCryst Pharma Common Stock 09058V103 82,476 -14,134 -14.63 233 -76.63 0.0024
2016-02-05 2015-12-31 13F BioCryst Pharma Common Stock 09058V103 96,610 96,610 997 0.0097
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.